S

Stereotaxis Inc
AMEX:STXS

Watchlist Manager
Stereotaxis Inc
AMEX:STXS
Watchlist
Price: 1.94 USD
Market Cap: 164.2m USD
Have any thoughts about
Stereotaxis Inc?
Write Note

Stereotaxis Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stereotaxis Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
S
Stereotaxis Inc
AMEX:STXS
Cash & Cash Equivalents
$14.7m
CAGR 3-Years
-30%
CAGR 5-Years
12%
CAGR 10-Years
3%
Becton Dickinson and Co
NYSE:BDX
Cash & Cash Equivalents
$4.5B
CAGR 3-Years
12%
CAGR 5-Years
54%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Cash & Cash Equivalents
$2.5B
CAGR 3-Years
9%
CAGR 5-Years
55%
CAGR 10-Years
26%
Stryker Corp
NYSE:SYK
Cash & Cash Equivalents
$3.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Cash & Cash Equivalents
$7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash & Cash Equivalents
$2.4B
CAGR 3-Years
21%
CAGR 5-Years
20%
CAGR 10-Years
17%

See Also

What is Stereotaxis Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
14.7m USD

Based on the financial report for Jun 30, 2024, Stereotaxis Inc's Cash & Cash Equivalents amounts to 14.7m USD.

What is Stereotaxis Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
3%

Over the last year, the Cash & Cash Equivalents growth was -36%. The average annual Cash & Cash Equivalents growth rates for Stereotaxis Inc have been -30% over the past three years , 12% over the past five years , and 3% over the past ten years .

Back to Top